Monitoring Eye Pressure Matters

3 million people are currently being treated for Glaucoma in the U.S., while an estimated 50% of Glaucoma sufferers are undiagnosed ​​
Reducing eye pressure is the only known way of slowing down or stopping the progression of Glaucoma
 80 million people are suffering from Glaucoma worldwide; and that number is expected to reach 112 million by 2040
Elevated eye pressure (IOP) is the primary and only modifiable risk factor of Glaucoma, the leading cause of irreversible blindness worldwide 

Better Informed Decisions for

Diagnosis and

Treatment of Glaucoma

What is Glaucoma?

A group of chronic and progressive eye diseases that permanently damage the optic nerve
It is the leading cause of irreversible blindness worldwide and is incurable, asymptomatic, and difficult to diagnose and treat.
 
Below, you can see how a patient's vision worsens over time because of Glaucoma.
Normal Vision 
Moderate Glaucoma
Advanced Glaucoma 
Irreversible Vision Loss
 

How is Glaucoma treated?

With prescription eye drops that lower eye pressure and prevent further damage to the optic nerve
Patients visit the eye doctor for a Glaucoma eye exam and are prescribed medication.
To make sure their medication is working, theyhave to visit their doctor regularly.
For every 1 mmHg reduction in eye pressure, the risk of optic nerve damage decreases by 11%

What is the biggest obstacle to Glaucoma Treatment?

Current methods of measuring eye pressure only give doctors one data point in time, for a few seconds every 3 to 6 months, which prevents them from fully understanding a patient's condition. A 2015 study* reported after 20 years of Glaucoma damage, 38.1% of patients were blind in one eye and 13.5% of patients were blind in both eyes.
*Susanna, R., De Moraes, C. G., Cioffi, G. A., & Ritch, R. (2015). Why do people (still) go blind from glaucoma?. Translational vision science & technology, 4(2), 1-1.

Your Vision in Your Hands

Smartlens has built the first electronics-free soft contact lens that measures eye pressure and its fluctuations throughout the day, giving doctors and patients a better tool for Glaucoma diagnosis and management.
Smartlens is the owner of a wide portfolio of technologies as a non-invasive, convenient and affordable way of IOP monitoring and remote patient management.

If you Have Any Questions Please Send Us a Message

Smartlens, Inc.

Sunnyvale, CA

  • LinkedIn

© 2018 - 2020 Smartlens, Inc.